Skip to main content
. 2018 Feb 2;15(4):4963–4969. doi: 10.3892/ol.2018.7942

Figure 1.

Figure 1.

Immunostaining of katanin p60 in normal breast glands, primary breast and bones metastatic tumors (n=10/group). (A) The expression of katanin p60 in healthy breast, primary breast cancer and bone metastatic tissues. The red arrows indicate the enlarged area. (B) Quantitative analysis demonstrated that the expression of katanin p60 protein increased significantly in primary and bone metastatic tissues compared with healthy breast tissue, **P<0.01 vs. normal breast..